Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · IEX Real-Time Price · USD
35.41
+0.11 (0.31%)
At close: Mar 28, 2024, 4:00 PM
35.40
-0.01 (-0.03%)
After-hours: Mar 28, 2024, 7:53 PM EDT
Tandem Diabetes Care Market Cap
Tandem Diabetes Care has a market cap or net worth of $2.33 billion as of March 28, 2024. Its market cap has decreased by -12.87% in one year.
Market Cap
2.33B
Enterprise Value
2.28B
1-Year Change
-12.87%
Ranking
Category
Stock Price
$35.41
Market Cap Chart
Since December 31, 2013, Tandem Diabetes Care's market cap has increased from $591.10M to $2.33B, an increase of 294.33%. That is a compound annual growth rate of 14.33%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2024 | 2.32B | 0.31% |
Mar 27, 2024 | 2.32B | 4.78% |
Mar 26, 2024 | 2.21B | 11.93% |
Mar 25, 2024 | 1.98B | -0.53% |
Mar 22, 2024 | 1.99B | -5.02% |
Mar 21, 2024 | 2.09B | -1.85% |
Mar 20, 2024 | 2.13B | 5.39% |
Mar 19, 2024 | 2.02B | -1.03% |
Mar 18, 2024 | 2.04B | 8.73% |
Mar 15, 2024 | 1.88B | 2.21% |
Mar 14, 2024 | 1.84B | -2.20% |
Mar 13, 2024 | 1.88B | -4.28% |
Mar 12, 2024 | 1.96B | 1.25% |
Mar 11, 2024 | 1.94B | -3.78% |
Mar 8, 2024 | 2.01B | 3.47% |
Mar 7, 2024 | 1.95B | 9.61% |
Mar 6, 2024 | 1.78B | -0.13% |
Mar 5, 2024 | 1.78B | -12.96% |
Mar 4, 2024 | 2.04B | 12.91% |
Mar 1, 2024 | 1.81B | 3.56% |
Feb 29, 2024 | 1.75B | 0.19% |
Feb 28, 2024 | 1.74B | -2.78% |
Feb 27, 2024 | 1.79B | -5.26% |
Feb 26, 2024 | 1.89B | -0.93% |
Feb 23, 2024 | 1.91B | 16.52% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AMN Healthcare Services | 2.36B |
Neumora Therapeutics | 2.35B |
LifeStance Health Group | 2.35B |
Recursion Pharmaceuticals | 2.34B |
Keros Therapeutics | 2.34B |
Dyne Therapeutics | 2.33B |
Privia Health Group | 2.32B |
Ginkgo Bioworks Holdings | 2.30B |